SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Mizuho cuts Corvus Pharmaceuticals target to $27 from $30

Valid market news retained in the public archive without immediate LiveCast distribution.

CRVS

Related stories